Approval · Notice of Compliance 17312 · 2012
P.G. 600: Notice of Compliance 17312
Issued February 7, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17312
- Date
- February 7, 2012
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Gonadotrophins
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| P.G. 600 | 00803472 | Marketed |
Medicinal ingredients
- GONADOTROPHIN SERUM (PMSG) 400 UNIT per VIAL
- CHORIONIC GONADOTROPIN 200 UNIT per VIAL